tiprankstipranks
Trending News
More News >
Cirtek Holdings Limited (HK:1433)
:1433
Hong Kong Market
Advertisement

Cirtek Holdings Limited (1433) AI Stock Analysis

Compare
1 Followers

Top Page

HK:1433

Cirtek Holdings Limited

(1433)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
Cirtek Holdings Limited's overall stock score is driven by its strong valuation, with a low P/E ratio and high dividend yield suggesting potential undervaluation. However, bearish technical indicators and concerns about cash flow management weigh on the score. The financial performance shows positive growth, but cash flow sustainability needs attention.

Cirtek Holdings Limited (1433) vs. iShares MSCI Hong Kong ETF (EWH)

Cirtek Holdings Limited Business Overview & Revenue Model

Company DescriptionCirtek Holdings Limited (1433) is a technology company based in the Philippines that specializes in the design, manufacturing, and testing of semiconductor products. The company operates primarily in the semiconductor sector, focusing on the production of advanced electronic components for various applications, including telecommunications, automotive, and consumer electronics. Cirtek's core products include radio frequency (RF) devices, antenna switches, and other integrated circuits that are essential for modern electronic systems.
How the Company Makes MoneyCirtek Holdings Limited generates revenue through the production and sale of semiconductor products, primarily serving clients in the telecommunications and consumer electronics industries. The company has a diversified revenue model that includes direct sales to original equipment manufacturers (OEMs) and contract manufacturing services for various technology firms. Key revenue streams include the sale of RF products, integrated circuits, and testing services. Cirtek also benefits from strategic partnerships with leading technology companies, which help to secure long-term contracts and enhance its market presence. Additionally, the company's focus on research and development allows it to innovate and expand its product offerings, thus driving growth and profitability.

Cirtek Holdings Limited Financial Statement Overview

Summary
Cirtek Holdings Limited demonstrates strong revenue growth and profitability improvements, with a solid balance sheet characterized by moderate leverage. However, the lack of cash flow data for 2024 raises concerns about cash generation capabilities, highlighting a need for better cash management.
Income Statement
75
Positive
Cirtek Holdings Limited demonstrated strong revenue growth of 47.97% in 2024, indicating a robust upward trajectory. The gross profit margin improved to 49.10%, showcasing efficient cost management. However, the net profit margin, while improving to 11.22%, still reflects room for profitability enhancements. EBIT and EBITDA margins also showed significant recovery, suggesting better operational performance.
Balance Sheet
70
Positive
The company maintains a healthy equity ratio of 54.37%, reflecting a strong equity base. The debt-to-equity ratio of 0.28 indicates moderate leverage, which is manageable. However, the return on equity of 25.15% suggests effective use of equity to generate income, yet there's potential to optimize further.
Cash Flow
55
Neutral
Cash flow statements reveal no operating or free cash flow in 2024, suggesting potential cash management challenges. Historical data indicates fluctuating cash flow, with a significant free cash flow growth in previous years. The absence of cash flow metrics for 2024 raises concerns about cash generation capabilities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue544.71M551.05M372.31M408.57M362.51M259.31M
Gross Profit268.06M270.62M162.55M173.46M158.01M130.20M
EBITDA82.58M89.45M15.32M48.68M50.58M39.51M
Net Income54.91M61.86M-25.68M12.56M14.98M1.65M
Balance Sheet
Total Assets435.71M452.43M369.43M395.07M401.03M361.69M
Cash, Cash Equivalents and Short-Term Investments76.22M68.52M34.16M62.33M102.10M114.74M
Total Debt59.66M67.67M48.18M51.07M46.15M54.61M
Total Liabilities193.39M206.50M174.39M155.81M150.74M124.82M
Stockholders Equity242.31M245.93M195.03M239.26M249.67M236.13M
Cash Flow
Free Cash Flow46.82M59.64M-10.86M-6.54M6.37M2.83M
Operating Cash Flow78.59M81.56M21.25M46.52M42.55M26.15M
Investing Cash Flow-34.78M-13.37M-31.13M-58.83M-35.63M-21.79M
Financing Cash Flow-21.99M-27.93M-21.05M-11.73M-19.43M71.92M

Cirtek Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.10
Negative
100DMA
0.09
Negative
200DMA
0.08
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
22.11
Positive
STOCH
20.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1433, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.10, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 22.11 is Positive, neither overbought nor oversold. The STOCH value of 20.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1433.

Cirtek Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
HK$176.00M3.2023.94%8.24%14.30%125.41%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
51
Neutral
€248.19M-14.53%0.34%-47.98%
47
Neutral
HK$202.68M-10.34%-5.02%-323.85%
46
Neutral
HK$224.36M-17.00%24.72%78.31%
45
Neutral
HK$177.80M-6.04%2.33%-20.43%-24.29%
44
Neutral
HK$166.85M-18.57%-6.47%-118.56%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1433
Cirtek Holdings Limited
0.09
0.04
80.00%
HK:0311
Luen Thai Holdings Limited
0.24
0.05
26.32%
HK:0294
Yangtzekiang Garment Co. Ltd.
0.86
-0.10
-10.42%
HK:1388
Embry Holdings Limited
0.40
0.05
14.29%
HK:0844
Greatime International Holdings Limited
0.45
0.19
73.08%
HK:8471
Reach New Holdings Ltd.
0.17
-0.09
-34.62%

Cirtek Holdings Limited Corporate Events

Cirtek Holdings Limited Announces 2025 AGM Agenda
Apr 25, 2025

Cirtek Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 20, 2025, in Hong Kong. The meeting will address several key resolutions, including the adoption of financial statements for the year ending December 31, 2024, re-election of directors, approval of a final dividend, and re-appointment of Ernst & Young as auditors. Additionally, a mandate will be discussed regarding the issuance of additional shares, which could impact the company’s capital structure and shareholder value.

Cirtek Holdings Limited Reports Turnaround with HK$61.9 Million Profit in 2024
Mar 31, 2025

Cirtek Holdings Limited reported a significant turnaround in its financial performance for the year ended December 31, 2024, with a profit attributable to owners of the company amounting to HK$61.9 million, compared to a loss of HK$25.7 million in the previous year. This improvement in profitability, despite a comprehensive loss due to exchange differences, reflects positively on the company’s operational efficiency and market positioning, potentially enhancing stakeholder confidence.

Cirtek Holdings Limited Declares Final Dividend for 2024
Mar 31, 2025

Cirtek Holdings Limited has announced a final ordinary cash dividend of HKD 0.0075 per share for the financial year ending December 31, 2024. The dividend will be paid on July 18, 2025, following shareholder approval on June 20, 2025, with the ex-dividend date set for June 24, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may influence investor sentiment and market perception of the company’s financial health.

Cirtek Holdings Postpones Board Meeting to Finalize 2024 Results
Mar 26, 2025

Cirtek Holdings Limited has announced the postponement of its board meeting originally scheduled for March 28, 2025, to March 31, 2025. This delay is due to the need for additional time to prepare and finalize the company’s audited annual results for the year ending December 31, 2024. The meeting will address the approval of these results and the consideration of a final dividend, impacting the company’s financial reporting timeline and potentially influencing stakeholder expectations.

Cirtek Holdings Announces Positive Profit Turnaround
Mar 14, 2025

Cirtek Holdings Limited announced a positive profit alert, expecting a profit before tax of not less than HK$65.0 million for the year ended December 31, 2024, marking a significant turnaround from a loss of approximately HK$19.7 million in the previous year. This improvement is attributed to increased sales orders and enhanced production efficiency, as well as effective cost management through global resource allocation.

Cirtek Holdings to Review Annual Results and Dividend Proposal
Mar 14, 2025

Cirtek Holdings Limited has announced a board meeting scheduled for March 28, 2025, to review and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend and address other business matters, potentially impacting the company’s financial strategy and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2025